Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), has begun shipping the first authorized generic versions of Mallinckrodt's Amitiza® (lubiprostone) 8 mcg and 24 mcg capsules. According to IQVIA™, Amitiza® capsule sales were approximately $427 million for the 12 months ended September 30,...
Prediction: Naut is continually revisiting oversold status, and has been in a significant downtrend for two weeks. With no real progress or relevant updates, and the recent attempts initiate a pump cycle being met with crickets, expect a revisit to the range of the previous bottom at around 0.0003, with a possibility of going lower, but a high probability that...